Identification of senescent, TREM2-expressing microglia in aging and Alzheimer’s disease model mouse brain
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 10×
“9 ,29), as well as markers associated with activated microglia, including TREM2 (refs.”
InfluentialSelf-citationOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“…I716V; and the London mutation, V717I), and PS1 (M146L/L286V) transgenes under transcriptional control of the neuron-specific mouse Ty-1 promoter 20 (5×FAD line Tg6799, The Jackson Laboratory); (2) Trem2 −/− 5×FAD and Trem2 +/+ 5×FAD mice on a C57/BL6 background, obtained from the laboratory of…”
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“Among the identified genes is triggering receptor expressed on myeloid cells 2 (TREM2), a polymorphism that is considered a risk factor in late-onset AD 5,6 .”
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 3×
“9 ,41,42), C5aR (ref.”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2×
“Genome-wide association studies have identified immune-related genes as risk factors in disease onset and severity, some of which are expressed by microglia 4–6 , the resident innate immune cells of the brain 7,8 .”
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277 · cited 3×
“Senes-cent cells are defined by stable cell cycle arrest, persistent DNA damage response and a senescence-associated secretory phenotype (SASP) 14 .”
InfluentialSelf-citationThe Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · cited 1×
“Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by several disease-escalating factors 1,2 , including local brain inflammation driven by innate immune cells, which significantly contributes to cognitive impairment 3 .”
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“32,35), p21 (refs.”
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 2×
“27,28) and CX3CR1 (refs.”
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511 · cited 1×
“9 ,26), P2RY12 (refs.”
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · cited 1×
“32,36) and p53 (refs.”
Object recognition test in mice
Leger, M., Quiedeville, A., Bouet, V., Haelewyn, B., Boulouard, M., Schumann-Bard, P., & Freret, T. (2013) · Nature Protocols · doi:10.1038/nprot.2013.155 · Cited by 1,357 · cited 2×
“The NOR test, which provides an index of recognition memory 55 , was performed using a protocol modified from Bevins and Besheer 75 .”
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 1×
“Other studies identified senescent microglia and astrocytes in mouse models of tauopathy 58 and aging 59 .”
Bevins, R. A., & Besheer, J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.205 · Cited by 1,277 · cited 1×
“The NOR test, which provides an index of recognition memory 55 , was performed using a protocol modified from Bevins and Besheer 75 .”
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267 · cited 1×
“Aging is recognized as a major risk factor for sporadic AD 12,13 .”
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263 · cited 1×
“…on a C57/BL6 background, obtained from the laboratory of Marco Colonna (Washington University), where they were generated as previously described 73 ; and (3) heterozygous DMhTAU transgenic mice, bearing two mutations (K257T/P301S) in the human-tau (hTAU) gene (double mutant (DM); on a…”
Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., & Schwartz, M. (2006) · Nature Neuroscience · doi:10.1038/nn1629 · Cited by 1,209 · cited 1×
“Over the last two decades, accumulated evidence has supported the contention that the immune system plays a pivotal role in supporting lifelong brain maintenance and functional plasticity 15–17 and has linked AD to the aging of the immune system 18,19 .”
Self-citationMicroglia development follows a stepwise program to regulate brain homeostasis
Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180 · cited 1×
“Genome-wide association studies have identified immune-related genes as risk factors in disease onset and severity, some of which are expressed by microglia 4–6 , the resident innate immune cells of the brain 7,8 .”
Self-citationZhou, Y., Song, W. M., Andhey, P. S., Swain, A., Levy, T., Miller, K. R., Poliani, P. L., Cominelli, M., Grover, S., Gilfillan, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0695-9 · Cited by 1,150 · cited 4×
“We further investigated the transcriptomic signature of the senescent microglia by conducting a meta-analysis of previously published single-nucleus RNA sequencing (snRNA-seq) data of WT, TREM2 −/− WT, TREM2 +/+ 5×FAD and TREM2 −/− 5×FAD mice 50 (Fig.”
InfluentialYang, J., Zhang, L., Yu, C., Yang, X.-F., & Wang, H. (2014) · Biomarker Research · doi:10.1186/2050-7771-2-1 · Cited by 1,099 · cited 1×
“22 ,23).”
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“32,34), γH2AX (refs.”
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032 · cited 3×
“53,54) led to the elimination of TREM2-dependent senescent microglia, but not of DAM, and was accompanied by improved cognitive performance in an AD mouse model.”
Self-citationA new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
Saul, D., Kosinsky, R. L., Atkinson, E. J., Doolittle, M. L., Zhang, X., LeBrasseur, N. K., Pignolo, R. J., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32552-1 · Cited by 1,022 · cited 1×
“This cluster was identified as senescent based on the SenMayo gene set 51 (Fig.”
Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977 · cited 1×
“…rule out the possibility that the favorable outcome on cognitive performance was also due to the elimination of senescent cells of other cell lineages beyond microglia, as other studies identified additional brain senescent cells, such as oligodendrocyte progenitor cells, in an AD mouse model 63 .”
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · cited 1×
“Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by several disease-escalating factors 1,2 , including local brain inflammation driven by innate immune cells, which significantly contributes to cognitive impairment 3 .”
Jaul, E., & Barron, J. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00335 · Cited by 946 · cited 1×
“Aging is recognized as a major risk factor for sporadic AD 12,13 .”
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 1×
“This state represents TREM2-expressing TREM2-expressing activated TREM2-activated microglia were previously seen in close proximity to amyloid plaque accumulation 48 ; therefore, we performed immunostaining to examine whether senesecent microglia have a different spatial distribution.”
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727 · cited 1×
“These findings are in line with reported results, showing that degenerative neuronal structures positive for tau (neuropil threads, neurofibrillary tangles and neurotic plaques) are invariably co-localized with severely dystrophic, rather than activated, microglial cells 56,57 .”
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699
Aging-induced type I interferon response at the choroid plexus negatively affects brain function
Baruch, K., Deczkowska, A., David, E., Castellano, J. M., Miller, O., Kertser, A., Berkutzki, T., Barnett-Itzhaki, Z., Bezalel, D., Wyss-Coray, T., et al. (2014) · Science · doi:10.1126/science.1252945 · Cited by 615 · cited 1×
“Over the last two decades, accumulated evidence has supported the contention that the immune system plays a pivotal role in supporting lifelong brain maintenance and functional plasticity 15–17 and has linked AD to the aging of the immune system 18,19 .”
Self-citationp19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615 · cited 1×
“32,33), pp38 (refs.”
Inflammatory Chemokine Transport and Presentation in HEV
Palframan, R. T., Jung, S., Cheng, G., Weninger, W., Luo, Y., Dorf, M., Littman, D. R., Rollins, B. J., Zweerink, H., Rot, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1361 · Cited by 550 · cited 1×
“22 ,23).”
Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain · doi:10.1093/brain/awv379 · Cited by 532 · cited 1×
“44), SiglecH (ref.”
Kipnis, J., Cohen, H., Cardon, M., Ziv, Y., & Schwartz, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402268101 · Cited by 510
Self-citationBaruch, K., Rosenzweig, N., Kertser, A., Deczkowska, A., Sharif, A. M., Spinrad, A., Tsitsou-Kampeli, A., Sarel, A., Cahalon, L., & Schwartz, M. (2015) · Nature Communications · doi:10.1038/ncomms8967 · Cited by 491
Self-citationMicroglial activation and tau propagate jointly across Braak stages
Pascoal, T. A., Benedet, A. L., Ashton, N. J., Kang, M. S., Therriault, J., Chamoun, M., Savard, M., Lussier, F. Z., Tissot, C., Karikari, T. K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01456-w · Cited by 490 · cited 2×
“This supports the suggestion that local brain inflammation is a major pathological factor contributing to cognitive deterioration, as found in other studies in mice 18,64 and in human disease 3 .”
White matter aging drives microglial diversity
Safaiyan, S., Besson-Girard, S., Kaya, T., Cantuti-Castelvetri, L., Liu, L., Ji, H., Schifferer, M., Gouna, G., Usifo, F., Kannaiyan, N., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.027 · Cited by 477 · cited 8×
“We conducted a comparative analysis of the transcriptomic signatures of cluster 2 senescent cells and WAM 52 .”
InfluentialBlocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes
Wang, T.-W., Johmura, Y., Suzuki, N., Omori, S., Migita, T., Yamaguchi, K., Hatakeyama, S., Yamazaki, S., Shimizu, E., Imoto, S., et al. (2022) · Nature · doi:10.1038/s41586-022-05388-4 · Cited by 469
Baruch, K., Deczkowska, A., Rosenzweig, N., Tsitsou-Kampeli, A., Sharif, A. M., Matcovitch-Natan, O., Kertser, A., David, E., Amit, I., & Schwartz, M. (2016) · Nature Medicine · doi:10.1038/nm.4022 · Cited by 425 · cited 1×
“…effect of targeting the inhibitory immune checkpoint pathway PD-1/PD-L1 in animal models of AD and tauopathy, through a mechanism that involves reduction of inflammation 67–70 ; additionally, it was shown that the same treatment reduces the abundance of senescent cells in all tested tissues 71,72 .”
Self-citationMolecular and spatial signatures of mouse brain aging at single-cell resolution
Allen, W. E., Blosser, T. R., Sullivan, Z. A., Dulac, C., & Zhuang, X. (2023) · Cell · doi:10.1016/j.cell.2022.12.010 · Cited by 423 · cited 1×
“62).”
Vaziri, H., West, M. D., Allsopp, R. C., Davison, T. S., Wu, Y.-S., Arrowsmith, C. H., Poirier, G. G., & Benchimol, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.6018 · Cited by 387 · cited 1×
“32,37).”
Inflammaging as a prodrome to Alzheimer's disease
Giunta, B., Fernandez, F., Nikolic, W. V., Obregon, D., Rrapo, E., Town, T., & Tan, J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-51 · Cited by 327 · cited 1×
“Over the last two decades, accumulated evidence has supported the contention that the immune system plays a pivotal role in supporting lifelong brain maintenance and functional plasticity 15–17 and has linked AD to the aging of the immune system 18,19 .”
Elucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325 · cited 2×
“For example, in animal models of amyloidosis, the expression of TREM2 is intricately linked to the state of microglial activation 9–11 .”
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
Schlepckow, K., Monroe, K. M., Kleinberger, G., Cantuti‐Castelvetri, L., Parhizkar, S., Xia, D., Willem, M., Werner, G., Pettkus, N., Brunner, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911227 · Cited by 324 · cited 1×
“Furthermore, TREM2 appears to promote the proliferation of microglia and their adoption of the DAM profile 9,60 .”
Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Song, W. M., Joshita, S., Zhou, Y., Ulland, T. K., Gilfillan, S., & Colonna, M. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171529 · Cited by 305
Mildner, A., Huang, H., Radke, J., Stenzel, W., & Priller, J. (2017) · Glia · doi:10.1002/glia.23097 · Cited by 301 · cited 2×
“27,28) and CX3CR1 (refs.”
TREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296 · cited 1×
“9 ,39,40), ApoE (refs.”
Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry
Han, G., Spitzer, M. H., Bendall, S. C., Fantl, W. J., & Nolan, G. P. (2018) · Nature Protocols · doi:10.1038/s41596-018-0016-7 · Cited by 264 · cited 1×
“Metals for conjugation were chosen to minimize noise and spillover between channels, according to guidelines in Han et al. 74 .”
Physiological and pathological consequences of cellular senescence
Burton, D. G. A., & Krizhanovsky, V. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1691-3 · Cited by 253 · cited 6×
“32,35), p21 (refs.”
InfluentialSelf-citationGasque, P., Singhrao, S. K., Neal, J. W., Götze, O., & Morgan, B. P. (1997) · Europe PMC (PubMed Central) · Cited by 234
Rosenzweig, N., Dvir-Szternfeld, R., Tsitsou-Kampeli, A., Keren-Shaul, H., Ben-Yehuda, H., Weill-Raynal, P., Cahalon, L., Kertser, A., Baruch, K., Amit, I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08352-5 · Cited by 227
Self-citationKamphuis, W., Kooijman, L., Schetters, S., Orre, M., & Hol, E. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.007 · Cited by 209 · cited 1×
“9 ,24,25) but expressed markers characteristic of homeostatic microglia (CD11b (refs.”
Strategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200 · cited 3×
“The senolytic drugs available today have limited applicability to humans due to their side effects and lack of specificity 53,66 .”
Self-citationApolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
Bancaro, N., Calì, B., Troiani, M., Elia, A. R., Arzola, R. A., Attanasio, G., Lai, P., Crespo, M., Gurel, B., Pereira, R., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.004 · Cited by 177 · cited 2×
“It is worth noting that the ApoE/TREM2/ERK signaling pathway was previously linked to the induction of senescent neutrophils 49 .”
Dystrophic microglia in late‐onset Alzheimer's disease
Streit, W. J., Khoshbouei, H., & Bechmann, I. (2020) · Glia · doi:10.1002/glia.23782 · Cited by 152 · cited 1×
“These findings are in line with reported results, showing that degenerative neuronal structures positive for tau (neuropil threads, neurofibrillary tangles and neurotic plaques) are invariably co-localized with severely dystrophic, rather than activated, microglial cells 56,57 .”
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading
Jain, N., Lewis, C. A., Ulrich, J. D., & Holtzman, D. M. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220654 · Cited by 146
Rosenmann, H., Grigoriadis, N., Eldar-Levy, H., Avital, A., Rozenstein‐Tsalkovich, L., Touloumi, O., Behar, L., Ben‐Hur, T., Avraham, Y., Berry, E., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.007 · Cited by 104 · cited 1×
“…73 ; and (3) heterozygous DMhTAU transgenic mice, bearing two mutations (K257T/P301S) in the human-tau (hTAU) gene (double mutant (DM); on a BALBc-C57/BL6 background), associated with severe disease manifestations of frontotemporal dementia in humans 21 , expressed under the natural tau promoter.”
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
Gisslén, M., Heslegrave, A., Veleva, E., Yilmaz, A., Andersson, L.-M., Hagberg, L., Spudich, S., Fuchs, D., Price, R. W., & Zetterberg, H. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000512 · Cited by 76
Siglec‐h on activated microglia for recognition and engulfment of glioma cells
Kopatz, J., Beutner, C., Welle, K., Bodea, L. G., Reinhardt, J., Claude, J., Linnartz‐Gerlach, B., & Neumann, H. (2013) · Glia · doi:10.1002/glia.22501 · Cited by 72 · cited 1×
“45 ) and CD39 to microglia, it remains unclear whether the activated microglia that fail to support the brain in aging or in AD are themselves becoming senescent or whether they are outcomes of distinct cellular pathways.”
Mercurio, D., Fumagalli, S., Schafer, M. K.-H., Pedragosa, J., Ngassam, L. D. C., Wilhelmi, V., Winterberg, S., Planas, A. M., Weihe, E., & De Simoni, M.-G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.820127 · Cited by 65
Jin, C., Shao, Y., Zhang, X., Xiang, J., Zhang, R., Sun, Z., Mei, S., Zhou, J., Zhang, J., & Shi, L. (2021) · Aging and Disease · doi:10.14336/ad.2021.0520 · Cited by 62 · cited 3×
“9 ,41,42), C5aR (ref.”
Joaquín Merino, J., Muñetón-Gómez, V., Alvárez, M.-I., & Toledano-Díaz, A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116125714 · Cited by 62 · cited 2×
“9 ,29), as well as markers associated with activated microglia, including TREM2 (refs.”
A New Gene Set Identifies Senescent Cells and Predicts Senescence-Associated Pathways Across Tissues
(2021) · doi:10.1101/2021.12.10.472095 · Cited by 58
Castellani, G., & Schwartz, M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.005 · Cited by 55 · cited 1×
“Genome-wide association studies have identified immune-related genes as risk factors in disease onset and severity, some of which are expressed by microglia 4–6 , the resident innate immune cells of the brain 7,8 .”
Self-citationKey role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
Ben-Yehuda, H., Arad, M., Peralta Ramos, J. M., Sharon, E., Castellani, G., Ferrera, S., Cahalon, L., Colaiuta, S. P., Salame, T.-M., & Schwartz, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00458-z · Cited by 48 · cited 1×
“This supports the suggestion that local brain inflammation is a major pathological factor contributing to cognitive deterioration, as found in other studies in mice 18,64 and in human disease 3 .”
Self-citationIdentification of distinct and age‐dependent p16High microglia subtypes
Talma, N., Gerrits, E., Wang, B., Eggen, B. J. L., & Demaria, M. (2021) · Aging Cell · doi:10.1111/acel.13450 · Cited by 46 · cited 1×
“Other studies identified senescent microglia and astrocytes in mouse models of tauopathy 58 and aging 59 .”
Dvir-Szternfeld, R., Castellani, G., Arad, M., Cahalon, L., Colaiuta, S. P., Keren-Shaul, H., Croese, T., Burgaletto, C., Baruch, K., Ulland, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00149-w · Cited by 44 · cited 1×
“TREM2 is associated with a state switch of microglia from resting to activated in animal models of amyloidosis (for example, 5×FAD), where microglia acquire the DAM state 9–11 , 47 .”
Self-citationThe role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models
Karanfilian, L., Tosto, M. G., & Malki, K. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.004 · Cited by 41
Xing, Z., Zuo, Z., Hu, D., Zheng, X., Wang, X., Yuan, L., Zhou, L., Qi, F., & Yao, Z. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.015 · Cited by 39
Jakovljevic, M., Lavrnja, I. C., Bozic, I. D., Milosevic, A., Bjelobaba, I. M., Savić, D. Z., Sévigny, J., Peković, S., Nedeljković, N., & Laketa, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00410 · Cited by 38
The involvement of microglia in Alzheimer's disease: a new dog in the fight
Moore, Z., Taylor, J. M., & Crack, P. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14546 · Cited by 29
Zou, Y., Gan, C., Xin, Z., Zhang, H., Zhang, Q., Lee, T. H., Pan, X., & Chen, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.769229 · Cited by 23
Senescent cells in the brain and where to find them
Rachmian, N., & Krizhanovsky, V. (2022) · FEBS Journal · doi:10.1111/febs.16649 · Cited by 20 · cited 1×
“The senolytic drugs available today have limited applicability to humans due to their side effects and lack of specificity 53,66 .”
Self-citationA TREM2 antibody energizes microglia
Zhao, N., & Bu, G. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01265-z · Cited by 16 · cited 1×
“Overall, this study suggests that TREM2 displays a dual activity in microglia, which should be carefully considered when contemplating TREM2 as a therapeutic target 65 .”
p16-dependent upregulation of PD-L1 impairs immunosurveillance of senescent cellsPreprint
Majewska, J., Agrawal, A., Mayo, A., Roitman, L., Chatterjee, R., Kralova, J. S., Landsberger, T., Katzenelenbogen, Y., Meir-Salame, T., Hagai, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.30.524522 · Cited by 5 · cited 1×
“…effect of targeting the inhibitory immune checkpoint pathway PD-1/PD-L1 in animal models of AD and tauopathy, through a mechanism that involves reduction of inflammation 67–70 ; additionally, it was shown that the same treatment reduces the abundance of senescent cells in all tested tissues 71,72 .”
Self-citationCD11c is not required by microglia to convey neuroprotection after prion infection
Carroll, J. A., Striebel, J. F., Baune, C., Chesebro, B. W., & Race, B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293301 · Cited by 2 · cited 1×
“9 ,24,25) but expressed markers characteristic of homeostatic microglia (CD11b (refs.”
Cited by
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2025) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 410
Carling, G. K., Fan, L., Foxe, N. R., Norman, K., Wong, M. Y., Zhu, D., Corona, C., Razzoli, A., Yu, F., Yarahmady, A., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.006 · Cited by 89
Yang, Y., Jn-Simon, N., He, Y., Sun, C., Zhang, P., Hu, W., Tian, T., Zeng, H., Basha, S., Huerta, A. S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00811-7 · Cited by 65
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype
Gross, P. S., Durán-Laforet, V., Ho, L. T., Melchor, G. S., Zia, S., Manavi, Z., Barclay, W. E., Lee, S. H., Shults, N., Selva, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57632-w · Cited by 80
Fancy, N. N., Smith, A. M., Caramello, A., Tsartsalis, S., Davey, K., Muirhead, R. C. J., McGarry, A., Jenkyns, M. H., Schneegans, E., Chau, V., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02727-9 · Cited by 48
Metadata
- Authors
- Rachmian, N., Medina, S., Cherqui, U., Akiva, H., Deitch, D., Edilbi, D., Croese, T., Salame, T. M., Ramos, J. M. P., Cahalon, L., Krizhanovsky, V., & Schwartz, M.
- Venue
- Nature Neuroscience
- Published
- 2024-04-18
- Volume
- 27
- Issue
- 6
- Pages
- 1116-1124
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W4394923597
- Cited by
- 180
- References
- 79
- FWCI
- 24.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.